Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Huabang Veterinary Pharmaceuticals, a subsidiary of Huabang Health, is a leading Chinese enterprise dedicated to the animal health sector. The company focuses on the research, production, and distribution of a wide array of veterinary products, including anti-infectives, antiparasitics, and biological vaccines for both livestock and pets. Operating out of GMP-certified facilities in Chongqing, it offers various formulations such as sterile injections, powders, and oral solutions. Huabang Veterinary Pharmaceuticals leverages the extensive R&D capabilities of its parent company to innovate in animal nutrition and disease prevention. Its products are widely utilized across China's agricultural sector and are increasingly exported to international markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Huabang Veterinary Pharmaceuticals.